Evidence map›Paper›PMID 15684326›Full record

ArticleThe Journal of experimental medicine2005

Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.

Stefan Kraft, Tony Fleming, James M Billingsley, Shih-Yao Lin, Marie-Hélène Jouvin, Peter Storz, Jean-Pierre Kinet

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Tetraspanins in the regulation of mast cell function.Medical microbiology and immunology · 2020
    Review
  5. Journal of veterinary research · 2019
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Tetraspanins in mast cells.Frontiers in immunology · 2012
    Article
  15. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2010
    Article
  16. Review
  17. Article
  18. Article
  19. Treatment strategies for allergy and asthma.Nature reviews. Immunology · 2008
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stefan KraftDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Tony Fleming
James M Billingsley
Shih-Yao Lin
Marie-Hélène Jouvin
Peter Storz
Jean-Pierre Kinet
Beth Israel Deaconess Medical Center · US

Funding

Calcium influx pathways inlymphocytes and mast cellsR01AI046734 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KINET, JEAN-PIERRE M · 2000 to 2008
$3.1M
NIAID NIH HHS AI46734-01NIAID NIH HHS R01 AI046734
6 · The paper itself

Abstract

High-affinity IgE receptor (FcepsilonRI) cross-linking on mast cells (MCs) induces secretion of preformed allergy mediators (degranulation) and synthesis of lipid mediators and cytokines. Degranulation produces many symptoms of immediate-type allergic reactions and is modulated by adhesion to surfaces coated with specific extracellular matrix (ECM) proteins. The signals involved in this modulation are mostly unknown and their contribution to allergic reactions in vivo is unclear. Here we report the generation of monoclonal antibodies that potently suppress FcepsilonRI-induced degranulation, but not leukotriene synthesis. We identified the antibody target as the tetraspanin CD63. Tetraspanins are membrane molecules that form multimolecular complexes with a broad array of molecules including ECM protein-binding beta integrins. We found that anti-CD63 inhibits MC adhesion to fibronectin and vitronectin. Furthermore, anti-CD63 inhibits FcepsilonRI-mediated degranulation in cells adherent to those ECM proteins but not in nonadherent cells. Thus the inhibition of degranulation by anti-CD63 correlates with its effect on adhesion. In support of a mechanistic linkage between the two types of inhibition, anti-CD63 had no effect on FcepsilonRI-induced global tyrosine phosphorylation and calcium mobilization but impaired the Gab2-PI3K pathway that is known to be essential for both degranulation and adhesion. Finally, we showed that these antibodies inhibited FcepsilonRI-mediated allergic reactions in vivo. These properties raise the possibility that anti-CD63 could be used as therapeutic agents in MC-dependent diseases.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAntibodies, MonoclonalAntigens, CDCalciumCell AdhesionCell LineFibrinogenFibronectinsHumansHypersensitivityImmunoglobulin EMast CellsPassive Cutaneous AnaphylaxisPhosphoproteinsPhosphorylationAdaptor Proteins, Signal TransducingAntibodies, MonoclonalAntigens, CDCalciumCD63 protein, humanCd63 protein, ratFibrinogenFibronectinsGAB2 protein, humanImmunoglobulin EPhosphoproteinsPlatelet Membrane GlycoproteinsPRKCD protein, humanPrkcd protein, ratProtein Kinase CProtein Kinase C-deltaReceptors, IgESerotoninTetraspanin 30TyrosineVitronectin

Identifiers

PMID15684326
PMCPMC2213034
OpenAlexW2107477480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.